Skip to content

Aug. 17 COVID-19 update: Additional doses of COVID-19 vaccine available for international travel

Those who've gotten two doses of different types of vaccines won't be able to travel to many countries. The provincial government is allowing those people to get extra doses of the same type of vaccine to meet travel requirements.
Covid-19 Vaccine Map
The provinces is allowing extra doses of COVID-19 vaccine to meet international travel requirements

The Government of Saskatchewan is permitting the administration of additional doses of COVID-19 vaccinations for Saskatchewan residents who may require them for international travel effective immediately.

All vaccines given in Canada are approved by Health Canada and are safe and effective, and offer good protection against all known strains of the virus including the Delta variant.

Some countries are requiring proof of vaccination with specific vaccines.  The most common is requiring two doses of the same mRNA vaccine such as Pfizer or Moderna.

Residents who received a combination of AstraZeneca, Pfizer or Moderna can receive a third dose of vaccine to match their last vaccine brand, as long as their last vaccination was Pfizer or Moderna.

Individuals who received two doses of Covishield or AstraZeneca are able to complete a schedule to support international travel requirements with two additional matching mRNA vaccines such as Pfizer or Moderna.

Individuals should check on the approved vaccines for the country, venue or destination they are intending to visit.

Proof of intent to travel will not be required to receive the vaccination.  Appointments can be booked at pharmacies offering vaccinations or watch for a pop-up clinic in a nearby location.

For more information visit www.saskatchewan.ca/covid19-vaccine.

 

COVID-19 Summary for August 17, 2021: 

  • From August 11 - 17, 13,758 doses of COVID-19 vaccine have been given in Saskatchewan, bringing the total number of vaccines administered in the province to 1,448,368.
  • As of August 17, 76 per cent of those 12+ have received their first dose and 66 per cent of those 12+ are fully vaccinated.
  • There were 820 new cases of COVID-19 to report in Saskatchewan from August 11 - 17, bringing the provincial total to 51,499 cases.  Four hundred and thirty-five recoveries were recorded during the same period.
  • The seven-day average of new COVID-19 cases in Saskatchewan is currently 117 (9.7 per 100,000).
  • Two new deaths were reported August 11 - 17.
  • There were 28 cases confirmed as Variants of Concern between August 11 - 17.  
  • As of August 17, there are 79 people in hospital: 68 are receiving inpatient care and 11 are in intensive care.  Sixty-one of the people in hospital (77%) are not fully vaccinated.
  • From August 11 - 17, there were 12,679 COVID-19 tests processed in Saskatchewan.

Daily provincial COVID-19 statistics by age, date and geographic zones including active cases, recoveries and confirmed variants of concern can be found at www.saskatchewan.ca/covid19-cases.

 

Stick it to COVID - Get Your Vaccination

All Saskatchewan residents 12 years and older are eligible for vaccination with additional doses administered following a 28-day interval.

  • A map of participating pharmacies across the province is available at www.saskatchewan.ca/covid19-pharmacies.  
  • The Saskatchewan Health Authority is holding pop-up and walk-in vaccination clinics throughout the province, targeting under- and unvaccinated communities.  Details on clinic locations and times is listed on the SHA website.  Please note clinics are subject to change based on demand, weather, etc.  Any changes to clinic hours and location will be updated online.

 

Living With COVID-19

For guidance on Living with COVID-19, including the requirements for self-isolation if you have a positive COVID-19 test, expectations around masking, information for businesses and workplaces and the visitation requirements for acute care as well as long term care and personal care homes, go to https://www.saskatchewan.ca/living-with-covid.